Trials / Completed
CompletedNCT04141969
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Optimal Health Research · Academic / Other
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the effectiveness of a nutraceutical in treating the lingering effects of Lyme Disease after antibiotic treatment.
Detailed description
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome will be evaluated during a double blind, placebo controlled study. This study is an expansion of RLP042019 NCT04078841 Treating Post-Lyme Disease Syndrome With Acetogenins
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | RLP | RLP nutraceutical |
| OTHER | Placebo | Inert brown powder |
Timeline
- Start date
- 2019-11-29
- Primary completion
- 2020-12-31
- Completion
- 2021-03-28
- First posted
- 2019-10-28
- Last updated
- 2021-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04141969. Inclusion in this directory is not an endorsement.